Detailed genetic and clinical analysis of a novel de novo variant in HPRT1: Case report of a female patient from Saudi Arabia with Lesch-Nyhan syndrome
- PMID: 36778911
- PMCID: PMC9908584
- DOI: 10.3389/fgene.2022.1044936
Detailed genetic and clinical analysis of a novel de novo variant in HPRT1: Case report of a female patient from Saudi Arabia with Lesch-Nyhan syndrome
Abstract
Background: Hypoxanthine-guanine phosphoribosyltransferase (HPRT1) deficiency is an inborn error of purine metabolism responsible for Lesch-Nyhan syndrome (LNS). The disease is inherited in an X-linked recessive manner and predominantly affects male individuals. Female individuals can carry a mutation as heterozygotes, but typically, they are asymptomatic because of the random inactivation of the affected allele. Nevertheless, although rare, heterozygote female individuals may manifest LNS with full characteristics. Herein, we describe a female patient from Saudi Arabia with LNS. Results: The patient (a 4-year-old girl) presented with typical characteristics of the disease, which include global developmental delay, self-mutilation, hyperuricemia, hypotonia, speech delay, spasticity, and seizures. Her general biochemical laboratory results were normal except for high levels of uric acid. The abdominal MRI\MRS, mostly unremarkable, showed bilateral echogenic foci within the renal collecting system. Genetic testing (whole-exome sequencing, iterative variant filtering, segregation analysis, and Sanger sequencing) pointed a novel de novo frameshift variant in HPRT1. X-inactivation assay using HpaII showed the presence of a 100% skewed X chromosome carrying the affected allele. RT-PCR of the cDNA indicated complete loss of the expression of the normal allele. Conclusion: Our study presents a female patient who has a severe case of LNSand found to be the 15th female patient with the disease in the world. The study emphasizethe need for a streamlined protocol that will help an early and accurate diagnosis of female LNS patients to avoid unnecessary interventions that lead to costly patient care.
Keywords: HPRT1; Lesch–Nyhan syndrome; RTPCR; X-inactivation assay; de novo.
Copyright © 2023 AlBakheet, AlQudairy, Alkhalifah, Almoaily, Kaya and Rahbeeni.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Aldhalaan H., AlBakheet A., AlRuways S., AlMutairi N., AlNakiyah M., AlGhofaili R., et al. (2021). A novel GEMIN4 variant in a consanguineous family leads to neurodevelopmental impairment with severe microcephaly, spastic quadriplegia, epilepsy, and cataracts. Genes (Basel) 13, 92. 10.3390/genes13010092 - DOI - PMC - PubMed
-
- Aral B., de Saint Basile G., Al-Garawi S., Kamoun P., Ceballos-Picot I. (1996). Novel nonsense mutation in the hypoxanthine guanine phosphoribosyltransferase gene and nonrandom X-inactivation causing Lesch-Nyhan syndrome in a female patient. Hum. Mutat. 7, 52–58. 10.1002/(SICI)1098-1004(1996)7:1<52::AID-HUMU7>3.0.CO;2-R - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
